Intratumoral administration of TILT-517 in an immunocompetent subcutaneous HapT1 pancreatic cancer model in Syrian hamsters significantly controlled tumor burden compared to the Ad5/3-E2F-d24 control lacking IL-7 expression [27]. This evidence concerns the gene IL7 and neoplasm.